Neuroblastoma: Difference between revisions
Jump to navigation
Jump to search
Jensflorian (talk | contribs) →General: update |
Jensflorian (talk | contribs) →Classification/grading: INRGSS |
||
| Line 96: | Line 96: | ||
*Mitoses/karyorrhectic cells. | *Mitoses/karyorrhectic cells. | ||
*Molecular abnormalities. | *Molecular abnormalities. | ||
International Neuroblastoma Risk Group Staging System (INRGSS) | |||
* L1: Locoregional tumor without Image-Definging Risk factors (IDRFs) | |||
* L2: Locoregional tumor with one or more IDRFs | |||
* M: Distant metastatic disease (except Ms) | |||
* Ms: INRG Stage L1 or L2 tumor with metastatic disease confined to skin and/or liver and/or bone marrow and age below 18 months. | |||
==IHC== | ==IHC== | ||